PolyPeptide US
Contract Development & Manufacturing Organization (CDMO) for peptide-based APIs.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at PolyPeptide US. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,454 people
- Headquarters
- Baar +6 more
- Founded
- 1996
- Type
- Public Company
- Total funding
- $161.8M
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages. Its broad portfolio reflects the opportunities in drug therapies across areas and with a large exposure to metabolic diseases, including GLP-1. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange. Find out more about our current vacancies at: https://polypeptide.teamtailor.com/
